|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor|
|Joonhong Sohn, Ju Byung Chae, Sun Young Lee, Soo-Youl Kim, June-Gone Kim|
Korean J Ophthalmol. 2010;24(1):29-34. Published online February 5, 2010
A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
Biological Therapies that Target Inflammatory Cytokines to Treat Uveitis
Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma?
Inflammatory monocytes—a novel therapeutic target for ALS?
Complement inhibitor CD55 and progesterone receptors as a novel therapeutic target for lipoxin A4 in endotoxin mediated inflammatory stress
Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors
The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders
Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target